Type 1 diabetes sufferers in the UK and certain other locations in Europe can now manage their condition directly from the iPhone thanks to Cambridge innovation. University of Cambridge spin-out ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest ... of a £1 coin that is worn on the upper arm and an app which can be used by users to record their real-time ...

Thankfully, with a bit more walking and some diet changes, like swapping white bread and pasta for wholemeal and making my ...

Emma Gill had bee been warned about her blood sugar levels being too high before, so she tested out a continuous glucose ...

Already granted breakthrough device designation from the FDA, the system will take the form of a small patch-like device similar to Abbott’s FreeStyle Libre 3 device. A smart ring developed by ...

Abbott announced results from its REFLECT real-world studies that show the use of FreeStyle Libre continuous glucose monitoring (CGM ... and HbA1c levels for adults with Type 1 diabetes;9 3) the risk ...

The use of CGM technology like Libre is now associated not ... which rises to 8.3% when excluding COVID-19 testing revenue. Abbott’s Medical Devices segment showed particular strength, with ...

(RTTNews) - Abbott Laboratories (ABT) Thursday announced positive data from REFLECT studies of its FreeStyle Libre continuous glucose monitoring (CGM) technology. The REFLECT studies, funded by ...

Abbott Laboratories has recently announced compelling study findings about its FreeStyle Libre® technology, which show a decrease in hospitalization risks for diabetes patients, potentially reducing ...